Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Biomira updates development activites at recent healthcare conference

Sep. 17, 1999

Boehringer Ingelheim's TNF-alpha-1a launched in Europe for soft tissue sarcoma

Sep. 16, 1999

M-Vax nearing commercialization in several markets

Sep. 16, 1999

Genzyme Molecular Oncology announces initiation of breast cancer vaccine trial

Sep. 16, 1999

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Sep. 14, 1999

LifeTime and Arkios enter oncology alliance

Sep. 13, 1999

Biomira revises collaboration with Chiron for Theratope vaccine

Sep. 7, 1999

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...